These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler. de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW. Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246 [Abstract] [Full Text] [Related]
5. The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance. Jones MD, Santo JG, Yakub B, Dennison M, Master H, Buckton G. Int J Pharm; 2010 May 31; 391(1-2):137-47. PubMed ID: 20211715 [Abstract] [Full Text] [Related]
9. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation. Dickhoff BH, de Boer AH, Lambregts D, Frijlink HW. Int J Pharm; 2006 Dec 11; 327(1-2):17-25. PubMed ID: 16920287 [Abstract] [Full Text] [Related]
10. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H. Chem Pharm Bull (Tokyo); 2004 Mar 11; 52(3):350-3. PubMed ID: 14993760 [Abstract] [Full Text] [Related]
14. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®. Hoe S, Young PM, Traini D. Drug Dev Ind Pharm; 2011 Nov 11; 37(11):1365-75. PubMed ID: 21554161 [Abstract] [Full Text] [Related]
15. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Luenberger H. Chem Pharm Bull (Tokyo); 2004 Aug 11; 52(8):938-42. PubMed ID: 15304985 [Abstract] [Full Text] [Related]